ProfileGDS5822 / ILMN_2531794
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 48% 27% 42% 2% 1% 18% 21% 10% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 120.948
GSM1276600PDAC Late Ablation Control 216.627
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 116.542
GSM1276603PDAC Late Ablation 23.32
GSM1276604PDAC Late Ablation 32.11
GSM1303940PDAC Late Ablation_anti-CTLA4 112.118
GSM1303941PDAC Late Ablation_anti-CTLA4 211.221
GSM1303942PDAC Late Ablation_anti-CTLA4 36.310